» Articles » PMID: 10508478

Asian-american Variants of Human Papillomavirus Type 16 Have Extensive Mutations in the E2 Gene and Are Highly Amplified in Cervical Carcinomas

Overview
Journal Int J Cancer
Specialty Oncology
Date 1999 Oct 3
PMID 10508478
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Human-papillomavirus (HPV)-E2 protein is involved in gene-expression regulation and replication of HPV genome. Disruption of the E2 gene during viral integration has been proposed as a mechanism of tumoral progression, since the expression of E6/E7 viral oncogenes is allowed. However, retention of E1/E2 genes and high viral amplification are frequently found in HPV16-positive carcinomas of some populations. In this study, we investigated whether retention of E1/E2 and viral amplification are associated with particular HPV16 E2 variants in cervical carcinomas. HPV16 detection, E1/E2 integrity and viral amplification were explored by Southern blot in 123 cervical carcinomas. HPV16 variants were identified by Southern blot and by sequencing E6, L1/MY and E2 regions. Of 46 HPV16-positive tumors, 34 were positive for E1/E2 and 14 of them showed a variant restriction pattern by mutations in E2. All 14 were Asian-American (AA) variants and, of 11 sub-classified, 6 were AA-a and 5 AA-c. Two E1/E2-negative tumors also contained the AA-c variant, while the remaining HPV16-positive tumors contained only European variants. The E2 gene of AA variants showed 24 mutations, 19 identical in both sub-classes. The 24 mutations were distributed throughout the entire gene and 19 result in 18 amino-acid changes. The AA variants were associated with E1/E2-positive carcinomas with more than 50 viral copies/cell (p = 0.035). The association of Asian-American E2 variants with retention of E1/E2 suggests that E2 variation may be an alternative mechanism de-regulating the expression of viral oncogenes.

Citing Articles

Epidemiology and Molecular Biology of HPV Variants in Cervical Cancer: The State of the Art in Mexico.

Munoz-Bello J, Carrillo-Garcia A, Lizano M Int J Mol Sci. 2022; 23(15).

PMID: 35955700 PMC: 9368912. DOI: 10.3390/ijms23158566.


Distribution of human papillomavirus genotypes in women with high-grade cervical intraepithelial lesions and cervical carcinoma and analysis of human papillomavirus-16 genomic variants.

Karadza M, Zidovec Lepej S, Planinic A, Grgic I, Corusic A, Planinic P Croat Med J. 2021; 62(1):68-79.

PMID: 33660963 PMC: 7976879.


Human papillomavirus genome variants and head and neck cancers: a perspective.

Combes J, Franceschi S Infect Agent Cancer. 2018; 13:13.

PMID: 29643933 PMC: 5891965. DOI: 10.1186/s13027-018-0185-6.


Different Association of Human Papillomavirus 16 Variants with Early and Late Presentation of Cervical Cancer.

Alfaro A, Juarez-Torres E, Medina-Martinez I, Mateos-Guerrero N, Bautista-Huerta M, Roman-Bassaure E PLoS One. 2016; 11(12):e0169315.

PMID: 28036379 PMC: 5201311. DOI: 10.1371/journal.pone.0169315.


Molecular mechanisms of HPV mediated neoplastic progression.

Senapati R, Senapati N, Dwibedi B Infect Agent Cancer. 2016; 11:59.

PMID: 27933097 PMC: 5123406. DOI: 10.1186/s13027-016-0107-4.